NCT04429984View on ClinicalTrials.gov

Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

April 22, 2023

Study Completion Date

April 22, 2023

Conditions
Gaucher Disease
Trial Locations (2)

110029

All India Institute of Medical Sciences, New Delhi

682041

Amrita Institute of Medical Sciences & Research Centre (AIMS), Kochi

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT04429984 - Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India | Biotech Hunter | Biotech Hunter